4.8 Review

Platelet-Mediated Protection of Cancer Cells From Immune Surveillance - Possible Implications for Cancer Immunotherapy

Journal

FRONTIERS IN IMMUNOLOGY
Volume 12, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fimmu.2021.640578

Keywords

NK cells; platelets; immunosuppressive; tumor microenvironment; antitumor immunity; metastasis; immunotherapy; cytotoxicity

Categories

Funding

  1. Swedish Cancer Society [2018/689]
  2. Radiumhemmets Forskningsfonder [181133]
  3. Cancer och Allergifonden
  4. Aroseniusfonden
  5. Karolinska Institute Strategic Research Area in Stem Cells and Regenerative Medicine
  6. Stockholm City Council [20170287]
  7. Swiss National Science Foundation (SNF) [P400PM_183909]
  8. Swiss National Science Foundation (SNF) [P400PM_183909] Funding Source: Swiss National Science Foundation (SNF)

Ask authors/readers for more resources

The interactions between platelets and cancer cells play a significant role in supporting tumor metastasis by promoting vascular evasion and establishing solid tumor metastasis, as well as contributing to an immunosuppressive tumor microenvironment. Platelets are a major source of TGF-beta, which is crucial in immunosuppression. While the interactions between platelets and solid tumors are well-studied, their physiological relevance in hematological malignancies requires further research.
The growing insights in the complex interactions between metastatic cancer-cells and platelets have revealed that platelet tumor cell interactions in the blood stream are an important factor supporting tumor metastasis. An increased coagulability of platelets facilitates the vascular evasion and establishment of solid tumor metastasis. Furthermore, platelets can support an immunosuppressive tumor microenvironment or shield tumor cells directly from engagement of cytotoxic lymphocytes as e.g., natural killer (NK) cells. Platelets are both in the tumor microenvironment and systemically the quantitatively most important source of TGF-beta, which is a key cytokine for immunosuppression in the tumor microenvironment. If similar platelet-tumor interactions are of physiological relevance in hematological malignancies remains less well-studied. This might be important, as T- and NK cell mediated graft vs. leukemia effects (GvL) are well-documented and malignant hematological cells have a high exposure to platelets compared to solid tumors. As NK cell-based immunotherapies gain increasing attention as a therapeutic option for patients suffering from hematological and other malignancies, we review the known interactions between platelets and NK cells in the solid tumor setting and discuss how these could also apply to hematological cancers. We furthermore explore the possible implications for NK cell therapy in patients with solid tumors and patients who depend on frequent platelet transfusions. As platelets have a protective and supportive effect on cancer cells, the impact of platelet transfusion on immunotherapy and the combination of immunotherapy with platelet inhibitors needs to be evaluated.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available